Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuri Pevzner

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|April 4, 2013
Recent advances in proteasome inhibitor discoveryYuri Pevzner, Rainer Metcalf, Melanie Kantor, et al.
Journal of Chemical Information and Modeling|August 26, 2014
Fragment-based docking: development of the CHARMMing Web user interface as a platform for computer-aided drug designYuri Pevzner, Emilie Frugier, Vinushka Schalk, et al.
Journal of Computational Chemistry|November 4, 2014
Development and implementation of (Q)SAR modeling within the CHARMMing web-user interfaceIwona E Weidlich, Yuri Pevzner, Benjamin T Miller, et al.
Plos One|December 16, 2014
Transforming growth factor β signaling overcomes dasatinib resistance in lung cancerEdna Gordian, Jiannong Li, Yuri Pevzner, et al.
Scientific Data|November 12, 2020
SAVI, in silico generation of billions of easily synthesizable compounds through expert-system type rulesHitesh Patel, Wolf-Dietrich Ihlenfeldt, Philip N Judson, et al.
Plos Computational Biology|July 25, 2014
Web-based computational chemistry education with CHARMMing I: Lessons and tutorialBenjamin T Miller, Rishi P Singh, Vinushka Schalk, et al.
Journal of Chemical Information and Modeling|July 4, 2012
Virtual target screening: validation using kinase inhibitorsDaniel N Santiago, Yuri Pevzner, Ashley A Durand, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|April 4, 2013
Recent advances in proteasome inhibitor discoveryYuri Pevzner, Rainer Metcalf, Melanie Kantor, et al.
Journal of Chemical Information and Modeling|August 26, 2014
Fragment-based docking: development of the CHARMMing Web user interface as a platform for computer-aided drug designYuri Pevzner, Emilie Frugier, Vinushka Schalk, et al.
Journal of Computational Chemistry|November 4, 2014
Development and implementation of (Q)SAR modeling within the CHARMMing web-user interfaceIwona E Weidlich, Yuri Pevzner, Benjamin T Miller, et al.
Plos One|December 16, 2014
Transforming growth factor β signaling overcomes dasatinib resistance in lung cancerEdna Gordian, Jiannong Li, Yuri Pevzner, et al.
Scientific Data|November 12, 2020
SAVI, in silico generation of billions of easily synthesizable compounds through expert-system type rulesHitesh Patel, Wolf-Dietrich Ihlenfeldt, Philip N Judson, et al.
Plos Computational Biology|July 25, 2014
Web-based computational chemistry education with CHARMMing I: Lessons and tutorialBenjamin T Miller, Rishi P Singh, Vinushka Schalk, et al.
Journal of Chemical Information and Modeling|July 4, 2012
Virtual target screening: validation using kinase inhibitorsDaniel N Santiago, Yuri Pevzner, Ashley A Durand, et al.
Pageof 1